amphotericin B

[desjeuxp at who.ch]

Jeffrey

I have just sent to Malika a list of references from India reporting a
progressive decrease in efficacy of Amphotericin B DOC in  VL patients which
led to a recommendation for increased dose and increased duration of
treatment.If somebody else is interested, please let me know!

Best personal regards.

P. Desjeux, WHO, CSR/EDC

-----Original Message-----
From: Jeffrey Shaw [mailto:jshaw at tba.com.br]
Sent: Wednesday, 1 November 2000 02:39
To: Multiple recipients of list
Subject: Fwd: amphotericin B


Please send any replies directly to Malika copy Leish-L

Many thanks

Jeffrey Shaw


>Sorry for my poor english.
>I am a old Phd Student and i loofing for information about
>AmB/leishmaniasis resistance (or other pathogene).
>Think you for your help.
>Sincerely yours
>MALIKA
>
>
>
>MALIKA LARABI
>ATER
>Laboratoire de Pharmacotechnie et Biopharmacie,
>UMR CNRS 8612,
>Faculté de Pharmacie de Paris Sud,
>5, rue Jean Baptiste Clement,
>92296 Chatenay-Malabry Cedex.
>tel 0146835584/5578 ou 0668665847. Fax: 0146619334
>Malika LARABI <malika.larabi at cep.u-psud.fr>